Yoshikawa, Yuki
Imamura, Michio
Yamaoka, Kenji
Kosaka, Yumi
Murakami, Eisuke
Morio, Kei
Fujino, Hatsue
Nakahara, Takashi
Okamoto, Wataru
Yamauchi, Masami
Kawaoka, Tomokazu
Tsuge, Masataka
Hiramatsu, Akira
Hayes, Clair Nelson
Aikata, Hiroshi
Fujitaka, Kazunori
Arihiro, Kouji
Hattori, Noboru
Chayama, Kazuaki http://orcid.org/0000-0003-4123-6290
Funding for this research was provided by:
Japan Agency for Medical Research and Development (19fk0210020h0003)
Article History
Received: 16 September 2020
Accepted: 26 October 2020
First Online: 16 November 2020
Compliance with ethical standards
:
: Michio Imamura has received research funding from Bristol-Myers Squibb and AbbVie. Hiroshi Aikata has received honoraria from Eisai and Bayer. Kazuaki Chayama has received honoraria from Bristol-Myers Squibb and MSD K.K., AbbVie, Gilead Science, Dainippon Sumitomo Pharma and Mitsubishi Tanabe Pharma and research funding fromĀ Gilead Science, Dainippon Sumitomo Pharma, MSD K.K., AbbVie, Eisai, TORAY, Otsuka Pharma, Chugai Pharma, Takeda Pharma and Roche.
: All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Informed consent was obtained from all patients for being included in the study.